Insider Trading April 28, 2026 04:32 PM

Everpure CVO John Colgrove Executes $2.03 Million Stock Sale via Pre-Arranged Plan

The transaction occurs amid strong annual returns and recent earnings beats for the company, formerly known as Pure Storage.

By Derek Hwang P
Everpure CVO John Colgrove Executes $2.03 Million Stock Sale via Pre-Arranged Plan
P

John Colgrove, serving as the Chief Visionary Officer of Everpure, Inc. (NASDAQ:P), has completed a sale of 28,935 shares of Class A Common Stock. The transaction, which took place on April 24, 2026, resulted in total proceeds of approximately $2,025,739. This divestment was conducted through the VCF Trust as part of a Rule 10b5-1 trading plan that had been established earlier in the year on January 8, 2026.

Key Points

  • Executive divestment through a scheduled Rule 10b5-1 plan totaling over $2 million.
  • Strong recent financial performance including an earnings beat in Q4 fiscal year 2026 with $1.06 billion in revenue.
  • Divergent analyst views ranging from price target reductions due to margin pressures to upgrades based on booking growth and AI infrastructure focus.

John Colgrove, the Chief Visionary Officer for Everpure, Inc. (NASDAQ:P), has finalized a significant sale of company equity. On April 24, 2026, Mr. Colgrove disposed of 28,935 shares of the firm's Class A Common Stock, a move that generated approximately $2,025,739 in total value.

The sale was executed within a specific price corridor, with individual share prices ranging from $70.00 to $70.17. On a weighted average basis, the shares were sold at $70.01 per unit. This transaction was handled indirectly via the VCF Trust and operated under the framework of a pre-arranged Rule 10b5-1 trading plan, which had been adopted on January 8, 2026.


Executive Holdings and Ownership Structure

Following this recent liquidation, Mr. Colgrove maintains a substantial position in the company. His direct holdings of Everpure, Inc. Class A Common Stock now total 6,725,221 shares. Beyond his direct ownership, he holds significant indirect interests through various legal entities and trusts:

  • Colgrove Family Living Trust: 601,959 shares
  • The EEC Irrevocable Trust: 2,715,000 shares (beneficiary is an immediate family member)
  • The RWC Irrevocable Trust: 2,715,000 shares (beneficiary is an immediate family member)

Market Context and Financial Performance

The insider activity occurs during a period of notable stock performance. Over the previous year, Everpure shares have seen a return of 63%. However, current market data suggests the stock is trading above its Fair Value, which indicates that there may be limited upside potential at these levels.

Everpure, which recently transitioned to this name from Pure Storage, has also demonstrated strong financial momentum. The company's fourth-quarter fiscal year 2026 earnings surpassed expectations from Wall Street. Specifically, the company reported revenue of $1.06 billion, exceeding the anticipated $1.03 billion, and delivered an earnings per share (EPS) of $0.69, which outperformed the projected $0.64.

Analyst Perspectives and Strategic Outlook

Market analysts have offered a diverse range of outlooks following these results. Piper Sandler has maintained an Overweight rating with a price target of $92, pointing toward growth potential in enterprise and cloud-based deals. Conversely, Wells Fargo lowered its price target from $100 to $90, though it kept an Overweight rating, noting that component costs may be exerting pressure on margins. Additionally, Northland upgraded the company to Outperform from Market Perform, setting a price target of $81 based on increased growth in bookings. A central pillar for the company's future trajectory is its strategic emphasis on AI-driven infrastructure.

Risks

  • Potential margin compression resulting from rising component costs, as noted by Wells Fargo.
  • Valuation risk, as the stock is currently trading above its estimated Fair Value, suggesting limited room for further upside.
  • The necessity of successful execution in AI-driven infrastructure to meet growth expectations.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026